You ask a question on 2c CR and predict the US trial will commence in Q2 2023. IMO if we're heading for Q22023 trial, it assumes successful results in Phase1 trial. In that case, the CR will be way above current price. We may even get non dilutionary capital from a potential partner.
You ask a question on 2c CR and predict the US trial will...
Add IBX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.318M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 543 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 1358 | 1 |
View Market Depth
| Last trade - 11.54am 08/10/2024 (20 minute delay) ? |
| IBX (ASX) Chart |
Day chart unavailable